Fatigue: Implications for the elderly

Consultant Pharmacist

Volumn 22, Issue 7, 2007, Pages 566-578

  Wick, Jeannette Y ^a   LaFleur, Joanne ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Chronic fatigue syndrome; Depression; Fatigue; Heart failure; Long term care; Parkinson's disease

Indexed keywords

ANEMIA; CANCER; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL PRACTICE; DEPRESSION; ELDERLY CARE; FATIGUE; FIBROMYALGIA; HEART FAILURE; HUMAN; LONG TERM CARE; PARKINSON DISEASE; PHARMACIST; PREVALENCE; REVIEW; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 34447529384     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.566     Document Type: Review

References (70)

1. Ahlberg K, Ekman T, Gaston-Johansson F et al. Assessment and management of cancer-related fatigue in adults. Lancet 2003;362:640-50.
2. Fernandes R, Stone P, Andrews P et al. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage 2006;32:245-54.
3. Liao S, Ferrell BA. Fatigue in an older population. J Am Geriatr Soc 2000;48:426-30.
4. Chen MK. The epidemiology of self-perceived fatigue among adults. Prev Med 1986;15:74-81.
5. Katerndahl DA. Differentiation of physical and psychological fatigue. Fam Pract Res J 1993;13:81-91.
6. Lai JS, Cella D, Chang CH et al. Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res 2003;12:485-501.
7. Ruffin MT 4th, Cohen M. Evaluation and management of fatigue. Am Fam Physician 1994;50:625-34.
8. Vogelzang NJ, Breitbart W, Cella D et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34(3, suppl 2):4-12.
9. Camarillo MA. The oncology patient's experience of fatigue. In: Whedon M. Quality of life: a nursing challenge. Philadelphia, PA: Meniscus; 1991:39-44.
10. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci 1990;299:313-8.
11. Avlund K, Rantanen T, Schroll M. Tiredness and subsequent disability in older adults: the role of walking limitations. J Gerontol A Biol Sci Med Sci 2006;61:1201-5.
12. Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life: "it feels like my body is just worn out." JAMA 2007;297:295-304.
13. Trendall J. Assessing fatigue in patients with COPD. Prof Nurse 200;16:1217-20.
14. Sharpe M, Wilks D. Fatigue. BMJ 2002;325:480-3.
15. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22(suppl 2):S386-S393.
16. Foley DJ, Monjan AA, Brown SL et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425-32.
17. Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years. J Am Geriatr Soc 2000;48:1234-40.
18. Cooke JR, Ancoli-Israel S. Sleep and its disorder in older adults. Psychiatr Clin North Am 2006;29:1077-93.
19. Morin CM, Colecchi C, Stone J et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-9.
20. National Institutes of Health. NIH Consensus and State-of-the-Science Statement. Available online at www.consensus.nih.gov. Updated June 2005. Accessed April 2007.
21. Maughan TS, James RD, Kerr DJ et al; British MRC Colorectal Cancer Working Party. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet 2002;359:1555-63.
22. Stone P, Richards M, Hardy J. Fatigue in patients with cancer. Eur J Cancer 1998;34:1670-6.
23. Curt GA, Breitbart W, Cella D et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353-60.
24. Given CW, Given B, Azzouz F et al. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 2001;21:456-66.
25. Mock V, Dow KH, Meares CJ et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991-1000.
26. Dimeo FC, Tilmann MH, Bertz H et al. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997;79:1717-22.
27. Dimeo FC, Stieglitz RD, Novelli-Fischer U et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999;85:2273-7.
28. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 2002;29:E85-E90.
29. Schwartz AL, Mori M, Gao R et al. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 2001;33:718-23.
30. Schwartz AL. Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract 2000;8:16-24.
31. Hartvig P, Aulin J, Wallenberg S et al. Physical exercise for cytotoxic drug-induced fatigue. J Oncol Pharm Pract 2006;12:183-91.
32. Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004;101:550-7.
33. Bruera E, Valero V, Driver L et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-8.
34. Hanna A, Sledge G, Mayer ML et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 2006;14:210-5.
35. Bruera E, Driver L, Barnes EA et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003;21:4439-43.
36. Homsi J, Nelson KA, Sarhill N et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care 2001;18:403-7.
37. Sarhill N, Walsh D, Nelson KA et al. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187-92.
38. Brown MA, Goldstein-Shirley J, Robinson J et al. The effects of a multi-modal intervention trial of light, exercise, and vitamins on women's mood. Women Health 2001;34:93-112.
39. Botts SR, Ryan M, Coffy G. Depression. In Tisdale JE, Miller DA, eds. Drug-induced diseases: prevention, detection, and management. Bethesda, Maryland: American Society of Health-System Pharmacists, Inc; 2005:216.
40. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-172.
41. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 gudeline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005;112:e154-e235.
42. Turvey CL, Schultz K, Arndt S et al. Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc 2002;50:2003-8.
43. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998;20:29-43.
44. Murberg TA, Bru E, Svebak S et al. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-year follow-up study. Int J Psychiatry Med 1999;29:311-26.
45. Kroenke K, Wood DR, Mangelsdorff AD et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 1988;260:929-34.
46. Wessely S, Chalder T, Hirsch S et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449-55.
47. Lyness JM, Caine ED, King DA et al. Psychiatric disorders in older primary care patients. J Gen Intern Med 1999;14:249-54.
48. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale. Eur J Neurol 2002;9:595-600.
49. Green TR. Bupropion for SSRI-induced fatigue. J Clin Psychiatry 1997;58:174.
50. Rolland Y, Pillard F, Klapouszczak A et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 2007;55:158-65.
51. Brenes GA, Williamson JD, Messier SP et al. Treatment of minor depression in older adults: a pilot study comparing sertraline and exercise. Aging Ment Health 2007;11:61-8.
52. Singh NA, Stavrinos TM, Scarbek Y et al. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci 2005;60:768-76.
53. Dorsey ER, Constantinescu R, Thompson JP et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-6.
54. Shulman LM, Taback RL, Rabinstein AA et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-7.
55. Friedman JH, Friedman H. Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001;16:1120-2.
56. Herlofson K, Larsen JP. The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003;107:1-6.
57. Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-37.
58. Reyes M, Nisenbaum R, Hoaglin DC et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003;163:1530-6.
59. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003;160:221-36.
60. Heim C, Wagner D, Maloney E et al. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry 2006;63:1258-66.
61. Fukuda K, Straus SE, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9.
62. Micromedex® Healthcare Series. Intranet database, version 5.1. Thomson Micromedex.
63. Straus SE, Dale JK, Tobi M et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988;319:1692-8.
64. Clark MR, Katon W, Russo J et al. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med 1995;98:187-95.
65. O'Malley PG, Jackson JL, Santoro J et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48:980-90.
66. Sharpe M, Hawton K, Simkin S et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. BMJ 1996;312:22-6.
67. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997;314:1647-52.
68. Fulcher KY, White PD. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2000;69:302-7.
69. Johnson JE, Nail LM, Lauver D et al. Reducing the negative impact of radiation therapy on functional status. Cancer 1988;61:46-51.
70. Burish TG, Snyder SL, Jenkins RA. Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol 1991;59:518-25.